Manage pulmonary nodules with a one-click AI solution

Aidence ECR 2022

13-17 July, Vienna, Austria

Meet us to learn:

  • Why Veye Lung Nodules is the preferred AI solution for NHS England’s Targeted Lung Health Checks
  • How Veye Lung Nodules is implemented at scale in 70+ sites across Europe
  • How you can lower the risk of misdiagnosis with the support of Veye Lung Nodules

Veye Lung Nodules

Automated lung nodule management on chest CT scans



  • >= 3mm and <=30mm in size
  • Solid and sub-solid nodules (part-solid/ground-glass opacity)


  • Diameters: long axis, perpendicular short axis, and the average axial diameter
  • Volume: 3mm, per-slice segmentation and 3D visualisation
Growth assessment

Growth assessment

  • Growth percentage
  • Volume doubling time (VDT)


  • Solid and sub-solid nodules
color blob
color blob

Join our workshop

Learn from Dr Greg Sorensen how radiologists across Europe use our AI solution in their daily practice.

Dr Greg Sorensen

President of DeepHealth and Head of RadNet’s AI division

Read bio

Dr Greg Sorensen

Dr Gregory Sorensen is the Co-Founder and President of DeepHealth. He is currently leading RadNet’s AI efforts, including the AI strategy, acquisitions, partnerships, licensing and product development.

A graduate of Caltech, Brigham Young University, Harvard and MIT, Dr Sorensen is a board-certified neuroradiologist, was a full professor at Harvard Medical School and co-directed a 300-person laboratory inside Massachusetts General Hospital. Immediately before founding DeepHealth, Dr Sorensen was the President & CEO of Siemens Healthcare North America, where he remains a supervisory board member.

From screening to routine practice: Using AI for early lung cancer detection

  • Thursday 14 July
  • 15:00 - 15:20 CEST
“Veye Lung Nodules improves the quality of cancer care because it automates and standardises the reporting of nodule measurements.”
Dr Thomas Jongsma Dr Thomas Jongsma Radiologist at Tergooi, the Netherlands
“Veye helps us read CT chest scans faster because it provides clear markers for nodules.”
Dr Floris Rietema and Dr Paul Algra Dr Floris Rietema and Dr Paul Algra Dr Floris Rietema, Interventional Radiologist, Dr Paul Algra, board member EuSoMII and Radiologist, Northwest Clinics, the Netherlands
“I love the detection indications. It is a simple yet effective solution that really helps me to report nodules faster. I directly know where to find them.”
Dr Caroline McCann Dr Caroline McCann Consultant Cardiothoracic Radiologist at Liverpool Heart and Chest Hospital NHS Trust Foundation, United Kingdom

Schedule a meeting

    Meet us at booth AI-26 | EXPO X1

    Dr Greg Sorensen

    President of DeepHealth and Head of RadNet’s AI division

    Mark-Jan Harte

    Co-founder & CEO

    Victor Groothengel

    Chief Commercial Officer

    Bas Giltay

    Head of Product

    Bob Vonk

    Business Manager Benelux

    Klaus Müller

    Business Manager DACH

    Floortje Jolink

    Jr. Product Manager

    Iuliana Grigore

    Marketing Director

    Book a demo

      * Required fields.
      For more information on how to unsubscribe, our privacy practices, and how we are committed to protecting and respecting your privacy, please review our Privacy Policy.